C-Reactive Protein Testing Market Size, Share, Growth & COVID-19 Impact Analysis, By Product (Reagent & Kits and Instruments), By Assay Type (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Immunoturbidimetric Assay, and Others), By Detection Range (Conventional CRP and hs-CRP), By Setting (Laboratory Testing and Point-of-Care (POC) Testing), By End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Regional Forecast, 2023-2030

  ATTRIBUTE

  DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 5.3% from 2023-2030

Unit

Value (USD billion)

Segmentation

By Product, Assay Type, Detection Range, Setting, End User, and Region

By Product

• Reagents & Kits
• Instruments

By Assay Type

• Chemiluminescence Immunoassay (CLIA)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Immunoturbidimetric Assay
• Others

By Detection Range

• Conventional CRP
• hs-CRP

By Setting

• Laboratory Testing
• Point-of-Care (POC) Testing

By End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Others

By Region

• North America (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country)
  • U.S.
  • Canada
• Europe (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, By Assay Type, By Detection Range, By Setting, By End User, By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa